Odyssey Therapeutics Rings the Opening Bell

About This Event

Odyssey Therapeutics (Nasdaq: ODTX), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that are designed to precisely target disease pathology, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Gary D. Glick, Ph.D., Founder, President, and Chief Executive Officer, rings the Opening Bell.